Inhibition of Human Acetyl- and Butyrylcholinesterase by Novel Carbamates of (-)- and (+)-tetrahydrofurobenzofuran and Methanobenzodioxepine.
From: Drug Design and Development Section, Laboratory of Neurosciences, Gerontology Research Center, National Institute on Aging, National Institutes of Health, 5600 Nathan Shock Drive, Baltimore, Maryland 21224, USA.
Journal of medicinal chemistry
- Publish Date: Apr 2006
- ISSN: 0022-2623
- Volume: 49
- Issue: 7
- Pages: 2174-85
- Medium: Print
- Language: English
- Citation (JAMA): Luo Weiming, Yu Qian-Sheng, Kulkarni Santosh S, et al. Inhibition of Human Acetyl- and Butyrylcholinesterase by Novel Carbamates of (-)- and (+)-tetrahydrofurobenzofuran and Methanobenzodioxepine.. J. Med. Chem. Apr 2006;49:2174-85
Abstract
A new enantiomeric synthesis utilizing classical resolution provided two novel series of optically active inhibitors of cholinesterase: (-)- and (+)-O-carbamoyl phenols of tetrahydrofurobenzofuran and methanobenzodioxepine. An additional two series of (-)- and (+)-O-carbamoyl phenols of pyrroloindole and furoindole were obtained by known procedures, and their anticholinesterase actions were similarly quantified against freshly prepared human acetyl- (AChE) and butyrylcholinesterase (BChE). Both enantiomeric forms of each series demonstrated potent cholinesterase inhibitory activity (with IC(50) values as low as 10 nM for AChE and 3 nM for BChE), with the exception of the (+)-O-carbamoyl phenols of pyrroloindole, which lacked activity (IC(50) values >1 microM). Based on the biological data of these four series, a structure-activity relationship (SAR) analysis was provided by molecular volume calculations. In addition, a probable transition-state model was established according to the known X-ray structure of a transition-state complex of Torpedo californica AChE-m-(N,N,N-trimethylammonio)-2,2,2-trifluoroacetophenone (TcAChE-TMTFA). This model proved valuable in explaining the enantioselectivity and enzyme subtype selectivity of each series. These carbamates are more potent than, or similarly potent to, anticholinesterases in current clinical use, providing not only inhibitors of potential clinical relevance but also pharmacological tools to define drug-enzyme binding interactions within an enzyme crucial in the maintenance of cognition and numerous systemic physiological functions in health, aging, and disease.
Mesh Headings (Keywords): Acetophenones, Acetylcholinesterase, Animals, Benzofurans, Butyrylcholinesterase, Carbamates, Cholinesterase Inhibitors, Crystallography, X-Ray, Furans, Heterocyclic Compounds, 3-Ring, Humans, Models, Molecular, Oxepins, Stereoisomerism, Structure-Activity Relationship, Torpedo
Check for Full Text / PubMed Unique Identifier (PMID): 16570913
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.